Literature DB >> 24250993

Apical hypertrophic cardiomyopathy in association with pulmonary artery hypertension.

Mehdi Peighambari1, Mozghan Parsaei, Anita Sadeghpour, Azin Alizadehasl.   

Abstract

Apical Hypertrophic Cardiomyopathy is an uncommon condition constituting 1% -2% of the cases with Hypertrophic Cardiomyopathy (HCM) diagnosis. We interestingly report two patients with apical hypertrophic cardiomyopathy in association with significant pulmonary artery hypertension without any other underlying reason for pulmonary hypertension. The patients were assessed by echocardiography, cardiac catheterization and pulmonary function parameters study.

Entities:  

Keywords:  Apical Hypertrophic Cardiomyopathy; Echocardiography; Pulmonary Artery Hypertension

Year:  2012        PMID: 24250993      PMCID: PMC3825366          DOI: 10.5681/jcvtr.2012.022

Source DB:  PubMed          Journal:  J Cardiovasc Thorac Res        ISSN: 2008-5117


  9 in total

1.  Apical hypertrophic cardiomyopathy: echocardiographic diagnosis with the use of intravenous contrast image enhancement.

Authors:  S Thanigaraj; J E Pérez
Journal:  J Am Soc Echocardiogr       Date:  2000-02       Impact factor: 5.251

2.  Long-term outcome in patients with apical hypertrophic cardiomyopathy.

Authors:  Maria J Eriksson; Brian Sonnenberg; Anna Woo; Paul Rakowski; Thomas G Parker; E Douglas Wigle; Harry Rakowski
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.

Authors:  Paolo Spirito; Camillo Autore
Journal:  Eur Heart J       Date:  2007-07-10       Impact factor: 29.983

4.  Cardiac fibroma mimicking apical hypertrophic cardiomyopathy: a case report and differential diagnosis.

Authors:  J P Veinot; B O'Murchu; H D Tazelaar; T A Orszulak; J B Seward
Journal:  J Am Soc Echocardiogr       Date:  1996 Jan-Feb       Impact factor: 5.251

5.  Pitfalls in diagnosis and clinical, echocardiographic, and hemodynamic findings in endomyocardial fibrosis: a 25-year experience.

Authors:  Walid M Hassan; Mohamed E Fawzy; Sumaya Al Helaly; Hesham Hegazy; Shahid Malik
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

6.  Gene mutations in apical hypertrophic cardiomyopathy.

Authors:  Michael Arad; Manual Penas-Lado; Lorenzo Monserrat; Barry J Maron; Mark Sherrid; Carolyn Y Ho; Scott Barr; Ahmad Karim; Timothy M Olson; Mitsohiro Kamisago; J G Seidman; Christine E Seidman
Journal:  Circulation       Date:  2005-11-01       Impact factor: 29.690

7.  Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.

Authors:  Hiroaki Kitaoka; Yoshinori Doi; Susan A Casey; Nobuhiko Hitomi; Takashi Furuno; Barry J Maron
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

8.  Apical hypertrophic cardiomyopathy might lead to misdiagnosis of ischaemic heart disease.

Authors:  Hamza Duygu; Mehdi Zoghi; Sanem Nalbantgil; Filiz Ozerkan; Azem Akilli; Mustafa Akin; Remzi Onder; Umit Erturk
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-31       Impact factor: 2.357

9.  Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study.

Authors:  Eui-Young Choi; Se-Joong Rim; Jong-Won Ha; Yong-Jin Kim; Sang-Chol Lee; Duk-Hyun Kang; Seung Woo Park; Jae-Kwan Song; Dae-Won Sohn; Namsik Chung
Journal:  Cardiology       Date:  2007-10-10       Impact factor: 1.869

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.